FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011186711> ?p ?o ?g. }

• W2011186711 endingPage "2049" @default.
• W2011186711 startingPage "2037" @default.
• W2011186711 abstract "The efficacy and safety of etoricoxib 60 mg/day in patients with established chronic low back pain (CLBP) were compared with those of diclofenac 150 mg/day in a 4-week, multicentre, randomized, double-blind, parallel-group trial. Four hundred and forty-six adult patients with CLBP (Quebec Task Force on Spinal Disorders Class 1 or 2) and with worsening pain upon discontinuation of pre-study analgesic medication were enrolled in the study. The study primary efficacy endpoint was change from baseline in Low Back Pain Intensity Scale (LBP-IS) score over the 4-week treatment period. Secondary and other efficacy endpoints included: changes in Roland and Morris Disability Questionnaire (RMDQ), Patient Global Assessment of Response to Therapy (PGART) and Low Back Pain Bothersomeness Scale (LBP-BS) scores. Early efficacy was assessed using PGART and LBP-IS scores 4 h after the first dose on the mornings of Days 1, 2 and 3. The overall safety and tolerability of etoricoxib 60 mg/day during 4 weeks of treatment were also assessed.The least-squares mean time-weighted change from baseline LBP-IS score over 4 weeks was -32.94 mm (95% CI -36.25, -29.63) for etoricoxib, indicating substantial efficacy in relief of pain. The treatment difference for the primary outcome was 2.51 mm (95% CI -1.50, 6.51), fulfilling the prespecified equivalence criterion of 95% confidence interval wholly within +/- 10 mm. Etoricoxib improved all secondary and other efficacy outcomes. There were no statistically significant between-group differences in the proportion of patients with one or more clinical adverse events (AEs) (etoricoxib 35%, diclofenac 39%), or the proportion of patients who discontinued due to AEs (etoricoxib 7%, diclofenac 5%).The results of this study confirm that, for adult patients with CLBP, etoricoxib 60 mg once daily over 4 weeks is effective for relief of pain and improvement of physical function and comparable to high-dose diclofenac 150 mg daily." @default.
• W2011186711 created "2016-06-24" @default.
• W2011186711 creator A5010347562 @default.
• W2011186711 creator A5013726200 @default.
• W2011186711 creator A5014809059 @default.
• W2011186711 creator A5016924982 @default.
• W2011186711 creator A5024156321 @default.
• W2011186711 creator A5027125132 @default.
• W2011186711 creator A5036058482 @default.
• W2011186711 creator A5038190872 @default.
• W2011186711 creator A5082503733 @default.
• W2011186711 date "2005-11-04" @default.
• W2011186711 modified "2023-10-14" @default.
• W2011186711 title "Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study" @default.
• W2011186711 cites W1964935101 @default.
• W2011186711 cites W1974235364 @default.
• W2011186711 cites W1987044093 @default.
• W2011186711 cites W1988212434 @default.
• W2011186711 cites W1998820417 @default.
• W2011186711 cites W2007061152 @default.
• W2011186711 cites W2028748639 @default.
• W2011186711 cites W2049615737 @default.
• W2011186711 cites W2088731142 @default.
• W2011186711 cites W2095090994 @default.
• W2011186711 cites W2106755981 @default.
• W2011186711 cites W2133178715 @default.
• W2011186711 cites W2138854915 @default.
• W2011186711 cites W2148997409 @default.
• W2011186711 cites W2151994459 @default.
• W2011186711 cites W2157229623 @default.
• W2011186711 cites W2165712294 @default.
• W2011186711 cites W2206411697 @default.
• W2011186711 doi "https://doi.org/10.1185/030079905x75069" @default.
• W2011186711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16368055" @default.
• W2011186711 hasPublicationYear "2005" @default.
• W2011186711 type Work @default.
• W2011186711 sameAs 2011186711 @default.
• W2011186711 citedByCount "60" @default.
• W2011186711 countsByYear W20111867112012 @default.
• W2011186711 countsByYear W20111867112013 @default.
• W2011186711 countsByYear W20111867112014 @default.
• W2011186711 countsByYear W20111867112015 @default.
• W2011186711 countsByYear W20111867112016 @default.
• W2011186711 countsByYear W20111867112017 @default.
• W2011186711 countsByYear W20111867112018 @default.
• W2011186711 countsByYear W20111867112019 @default.
• W2011186711 countsByYear W20111867112020 @default.
• W2011186711 countsByYear W20111867112021 @default.
• W2011186711 countsByYear W20111867112022 @default.
• W2011186711 countsByYear W20111867112023 @default.
• W2011186711 crossrefType "journal-article" @default.
• W2011186711 hasAuthorship W2011186711A5010347562 @default.
• W2011186711 hasAuthorship W2011186711A5013726200 @default.
• W2011186711 hasAuthorship W2011186711A5014809059 @default.
• W2011186711 hasAuthorship W2011186711A5016924982 @default.
• W2011186711 hasAuthorship W2011186711A5024156321 @default.
• W2011186711 hasAuthorship W2011186711A5027125132 @default.
• W2011186711 hasAuthorship W2011186711A5036058482 @default.
• W2011186711 hasAuthorship W2011186711A5038190872 @default.
• W2011186711 hasAuthorship W2011186711A5082503733 @default.
• W2011186711 hasConcept C126322002 @default.
• W2011186711 hasConcept C14184104 @default.
• W2011186711 hasConcept C142724271 @default.
• W2011186711 hasConcept C168563851 @default.
• W2011186711 hasConcept C1862650 @default.
• W2011186711 hasConcept C197934379 @default.
• W2011186711 hasConcept C203092338 @default.
• W2011186711 hasConcept C204787440 @default.
• W2011186711 hasConcept C2776214540 @default.
• W2011186711 hasConcept C2778375690 @default.
• W2011186711 hasConcept C2778715236 @default.
• W2011186711 hasConcept C2779826273 @default.
• W2011186711 hasConcept C2780820201 @default.
• W2011186711 hasConcept C2780907711 @default.
• W2011186711 hasConcept C42219234 @default.
• W2011186711 hasConcept C71924100 @default.
• W2011186711 hasConceptScore W2011186711C126322002 @default.
• W2011186711 hasConceptScore W2011186711C14184104 @default.
• W2011186711 hasConceptScore W2011186711C142724271 @default.
• W2011186711 hasConceptScore W2011186711C168563851 @default.
• W2011186711 hasConceptScore W2011186711C1862650 @default.
• W2011186711 hasConceptScore W2011186711C197934379 @default.
• W2011186711 hasConceptScore W2011186711C203092338 @default.
• W2011186711 hasConceptScore W2011186711C204787440 @default.
• W2011186711 hasConceptScore W2011186711C2776214540 @default.
• W2011186711 hasConceptScore W2011186711C2778375690 @default.
• W2011186711 hasConceptScore W2011186711C2778715236 @default.
• W2011186711 hasConceptScore W2011186711C2779826273 @default.
• W2011186711 hasConceptScore W2011186711C2780820201 @default.
• W2011186711 hasConceptScore W2011186711C2780907711 @default.
• W2011186711 hasConceptScore W2011186711C42219234 @default.
• W2011186711 hasConceptScore W2011186711C71924100 @default.
• W2011186711 hasIssue "12" @default.
• W2011186711 hasLocation W20111867111 @default.
• W2011186711 hasLocation W20111867112 @default.
• W2011186711 hasOpenAccess W2011186711 @default.
• W2011186711 hasPrimaryLocation W20111867111 @default.
• W2011186711 hasRelatedWork W2010221017 @default.

• next